Pathway enrichment analysis | |||||||||
---|---|---|---|---|---|---|---|---|---|
Source | Term_name | Term_id | Adjusted_p_value | Negative_log10_of_adjusted_p_value | Term_size | Query_size | Intersection_size | Effective_domain_size | Intersections |
A: Maximum vs autopsy | |||||||||
GO:BP | Myelination | GO:0042552 | 0.00168791 | 2.77265077 | 139 | 43 | 6 | 17906 | PLP1, MAG, UGT8, CD9, PLLP, SH3TC2 |
GO:BP | Ensheathment of neurons | GO:0007272 | 0.00191291 | 2.71830651 | 142 | 43 | 6 | 17906 | PLP1, MAG, UGT8, CD9, PLLP, SH3TC2 |
GO:BP | Axon ensheathment | GO:0008366 | 0.00191291 | 2.71830651 | 142 | 43 | 6 | 17906 | PLP1, MAG, UGT8, CD9, PLLP, SH3TC2 |
GO:BP | Oligodendrocyte development | GO:0014003 | 0.04500542 | 1.34673519 | 47 | 22 | 3 | 17906 | PLP1, MAG, CD9 |
B: Maximum vs minimum | |||||||||
GO:BP | Ensheathment of neurons | GO:0007272 | 1.44E−11 | 10.8420434 | 142 | 158 | 17 | 17906 | PLP1,KLK6,UGT8,CLDN11,ASPA,SH3TC2,MAG,NKX6-2,FA2H,CNTN2,TMEM98,CD9,GAL3ST1,ABCA2,PLLP,BCAS1,SOX10 |
GO:BP | Axon ensheathment | GO:0008366 | 1.44E−11 | 10.8420434 | 142 | 158 | 17 | 17906 | PLP1,KLK6,UGT8,CLDN11,ASPA,SH3TC2,MAG,NKX6-2,FA2H,CNTN2,TMEM98,CD9,GAL3ST1,ABCA2,PLLP,BCAS1,SOX10 |
GO:BP | Myelination | GO:0042552 | 1.72E−10 | 9.76340897 | 139 | 158 | 16 | 17906 | PLP1,KLK6,UGT8,ASPA,SH3TC2,MAG,NKX6-2,FA2H,CNTN2,TMEM98,CD9,GAL3ST1,ABCA2,PLLP,BCAS1,SOX10 |
GO:BP | Oligodendrocyte differentiation | GO:0048709 | 9.24E−09 | 8.03431166 | 101 | 158 | 13 | 17906 | SLC45A3,PLP1,ASPA,MAG,NKX6-2,FA2H,CNTN2,TMEM98,CD9,ABCA2,BOK,DAAM2,SOX10 |
GO:BP | Axon ensheathment in central nervous system | GO:0032291 | 2.50E−08 | 7.60287967 | 23 | 158 | 8 | 17906 | PLP1,ASPA,MAG,NKX6-2,FA2H,CNTN2,ABCA2,SOX10 |
GO:BP | Central nervous system myelination | GO:0022010 | 2.50E−08 | 7.60287967 | 23 | 158 | 8 | 17906 | PLP1,ASPA,MAG,NKX6-2,FA2H,CNTN2,ABCA2,SOX10 |
GO:BP | Oligodendrocyte development | GO:0014003 | 4.89E−07 | 6.311047 | 47 | 158 | 9 | 17906 | PLP1,ASPA,MAG,NKX6-2,FA2H,CNTN2,CD9,ABCA2,SOX10 |
GO:BP | Gliogenesis | GO:0042063 | 2.13039E−05 | 4.67154125 | 310 | 134 | 15 | 17906 | LRP2,SLC45A3,PLP1,ASPA,SH3TC2,MAG,NKX6-2,FA2H,CNTN2,TMEM98,CD9,CERS2,ABCA2,BOK,DAAM2 |
GO:BP | Glial cell differentiation | GO:0010001 | 2.48143E−05 | 4.60529884 | 226 | 158 | 14 | 17906 | SLC45A3,PLP1,ASPA,SH3TC2,MAG,NKX6-2,FA2H,CNTN2,TMEM98,CD9,ABCA2,BOK,DAAM2,SOX10 |
GO:BP | Glial cell development | GO:0021782 | 9.74491E−05 | 4.01122223 | 121 | 109 | 9 | 17906 | PLP1,ASPA,SH3TC2,MAG,NKX6-2,FA2H,CNTN2,CD9,ABCA2 |
GO:BP | Sphingolipid biosynthetic process | GO:0030148 | 0.000460392 | 3.33687211 | 105 | 109 | 8 | 17906 | UGT8,ELOVL1,PLPP2,FA2H,P2RX7,CERS2,GAL3ST1,ABCA2 |
GO:BP | Regulation of gliogenesis | GO:0014013 | 0.000494076 | 3.30620614 | 132 | 158 | 10 | 17906 | LRP2,SLC45A3,ASPA,MAG,NKX6-2,CNTN2,TMEM98,CERS2,DAAM2,SOX10 |
GO:BP | Nervous system development | GO:0007399 | 0.000672174 | 3.17251812 | 2432 | 160 | 46 | 17906 | LRP2,AQP1,SLC45A3,MOG,PLP1,KLK6,UGT8,CLDN11,SPP1,GLDN,GJB1,ASPA,MOBP,SH3TC2,C21ORF91,MAG,S1PR5,NKX6-2,FA2H,CNTN2,DOCK10,TMEM98,CD9,USH1C,SEMA4D,TNC,NDE1,CERS2,MYO1D,GAL3ST1,ABCA2,PLLP,ZNF536,SEMA6A,BOK,SYNJ2,SEMA3B,MAN2A1,BCAS1,DAAM2,KIF13B,WHRN,FRYL,SFRP1,SOX10,MAP4K4 |
GO:BP | Neurogenesis | GO:0022008 | 0.000902115 | 3.04473832 | 1679 | 166 | 37 | 17906 | LRP2,SLC45A3,PLP1,KLK6,UGT8,SPP1,GLDN,ASPA,SH3TC2,C21ORF91,MAG,S1PR5,NKX6-2,FA2H,CNTN2,DOCK10,TMEM98,CD9,USH1C,SEMA4D,TNC,NDE1,CERS2,ABCA2,ZNF536,SEMA6A,BOK,SEMA3B,MAN2A1,DAAM2,KIF13B,WHRN,FRYL,SFRP1,SOX10,MAP4K4,LTK |
GO:BP | Cell development | GO:0048468 | 0.000919176 | 3.03660132 | 2215 | 160 | 43 | 17906 | LRP2,SLC45A3,PLP1,KLK6,UGT8,SPP1,GLDN,ASPA,TYMS,DYSF,SH3TC2,DOCK5,C21ORF91,MAG,S1PR5,LDB3,CAPN3,NKX6-2,FA2H,CNTN2,PIP4K2A,DOCK10,TMEM98,CD9,USH1C,SEMA4D,TNC,CERS2,ABCA2,TJP2,ZNF536,SEMA6A,SEMA3B,MAN2A1,CLIC4,CFL2,DAAM2,KIF13B,WHRN,FRYL,SFRP1,SOX10,MAP4K4 |
GO:BP | Regulation of glial cell differentiation | GO:0045685 | 0.001515404 | 2.81947151 | 73 | 79 | 6 | 17906 | SLC45A3,ASPA,MAG,NKX6-2,CNTN2,TMEM98 |
GO:BP | Regeneration | GO:0031099 | 0.003378801 | 2.4712374 | 209 | 96 | 9 | 17906 | KLK6,SPP1,TYMS,DYSF,MAG,CAPN3,CD9,TNC,CERS2 |
GO:BP | Ceramide biosynthetic process | GO:0046513 | 0.00370985 | 2.4306437 | 64 | 105 | 6 | 17906 | UGT8,ELOVL1,FA2H,P2RX7,CERS2,GAL3ST1 |
GO:BP | Membrane lipid biosynthetic process | GO:0046467 | 0.005378894 | 2.26930705 | 145 | 109 | 8 | 17906 | UGT8,ELOVL1,PLPP2,FA2H,P2RX7,CERS2,GAL3ST1,ABCA2 |
GO:BP | Negative regulation of neurogenesis | GO:0050768 | 0.006339891 | 2.19791821 | 303 | 160 | 13 | 17906 | SPP1,MAG,NKX6-2,CNTN2,TMEM98,SEMA4D,CERS2,ZNF536,SEMA6A,SEMA3B,DAAM2,SOX10,MAP4K4 |
GO:BP | Galactosylceramide biosynthetic process | GO:0006682 | 0.007164655 | 2.14480471 | 6 | 105 | 3 | 17906 | UGT8,FA2H,GAL3ST1 |
GO:BP | Galactolipid biosynthetic process | GO:0019375 | 0.007164655 | 2.14480471 | 6 | 105 | 3 | 17906 | UGT8,FA2H,GAL3ST1 |
GO:BP | Regulation of neurogenesis | GO:0050767 | 0.007966259 | 2.09874557 | 856 | 166 | 23 | 17906 | LRP2,SLC45A3,KLK6,SPP1,ASPA,C21ORF91,MAG,S1PR5,NKX6-2,CNTN2,TMEM98,SEMA4D,CERS2,ZNF536,SEMA6A,SEMA3B,MAN2A1,DAAM2,KIF13B,SFRP1,SOX10,MAP4K4,LTK |
GO:BP | Cellular component morphogenesis | GO:0032989 | 0.010095286 | 1.99588137 | 1177 | 160 | 27 | 17906 | LRP2,UGT8,ENPP2,SPP1,ERMN,DOCK5,CDH19,MAG,LDB3,CAPN3,CNTN2,P2RX7,DOCK10,CD9,SEMA4D,WIPF1,ABCA2,CDC42EP1,SEMA6A,SEMA3B,PHLDB1,CLIC4,CFL2,KIF13B,WHRN,FRYL,MAP4K4 |
GO:BP | Sphingolipid metabolic process | GO:0006665 | 0.011698213 | 1.93188047 | 161 | 109 | 8 | 17906 | UGT8,ELOVL1,PLPP2,FA2H,P2RX7,CERS2,GAL3ST1,ABCA2 |
GO:BP | Negative regulation of nervous System development | GO:0051961 | 0.013118962 | 1.88210053 | 324 | 160 | 13 | 17906 | SPP1,MAG,NKX6-2,CNTN2,TMEM98,SEMA4D,CERS2,ZNF536,SEMA6A,SEMA3B,DAAM2,SOX10,MAP4K4 |
GO:BP | Regulation of cell projection organization | GO:0031344 | 0.015838735 | 1.8002795 | 704 | 166 | 20 | 17906 | ANLN,KLK6,ENPP2,SPP1,ERMN,C21ORF91,MAG,CNTN2,P2RX7,USH1C,SEMA4D,CERS2,PLD1,CDC42EP1,SEMA6A,SEMA3B,KIF13B,SFRP1,MAP4K4,LTK |
GO:BP | System development | GO:0048731 | 0.018013177 | 1.74440968 | 5020 | 167 | 73 | 17906 | LRP2,AQP1,SLC45A3,MOG,PLP1,ANLN,DMRT2,PCSK6,KLK6,UGT8,CLDN11,ENPP2,SPP1,GLDN,GJB1,ASPA,TYMS,TF,MOBP,DYSF,ELOVL1,SH3TC2,ADAMTS1,C21ORF91,MAG,S1PR5,LDB3,CAPN3,NKX6-2,FA2H,CNTN2,PIP4K2A,P2RX7,ATF3,DOCK10,TMEM98,CD9,CRYAB,USH1C,SEMA4D,TNC,NDE1,CERS2,MYO1D,TGFA,GAL3ST1,ABCA2,PLLP,ZNF536,RASSF2,SEMA6A,BOK,SYNJ2,SEMA3B,PHLDB1,MAN2A1,CLIC4,CFL2,BCAS1,DAAM2,KIF13B,WHRN,GLIPR2,FGF1,MCAM,FRYL,PLAAT3,SFRP1,SOX10,MAP4K4,COL5A2,LTK,CARTPT |
GO:BP | Glycosylceramide biosynthetic process | GO:0046476 | 0.019890103 | 1.70136298 | 8 | 105 | 3 | 17906 | UGT8,FA2H,GAL3ST1 |
GO:BP | Central nervous system development | GO:0007417 | 0.022798319 | 1.64209718 | 1031 | 158 | 24 | 17906 | LRP2,AQP1,SLC45A3,MOG,PLP1,KLK6,UGT8,ASPA,C21ORF91,MAG,NKX6-2,FA2H,CNTN2,TMEM98,CD9,NDE1,MYO1D,ABCA2,BOK,SYNJ2,DAAM2,WHRN,SFRP1,SOX10 |
GO:BP | Lipid biosynthetic process | GO:0008610 | 0.023671623 | 1.62577197 | 711 | 155 | 19 | 17906 | SLC45A3,PLP1,UGT8,ELOVL1,PLPP2,FA2H,SLC44A1,PIP4K2A,P2RX7,CYB5R2,CERS2,PLD1,GAL3ST1,ABCA2,ACSL1,SYNJ2,GPD1,FGF1,PLAAT3 |
GO:BP | Regulation of cell development | GO:0060284 | 0.027719447 | 1.55721544 | 991 | 166 | 24 | 17906 | LRP2,SLC45A3,KLK6,SPP1,ASPA,DOCK5,C21ORF91,MAG,S1PR5,NKX6-2,CNTN2,TMEM98,SEMA4D,CERS2,ZNF536,SEMA6A,SEMA3B,MAN2A1,DAAM2,KIF13B,SFRP1,SOX10,MAP4K4,LTK |
GO:BP | Positive regulation of bleb assembly | GO:1904172 | 0.028707127 | 1.54201028 | 2 | 71 | 2 | 17906 | ANLN,P2RX7 |
GO:BP | Regulation of bleb assembly | GO:1904170 | 0.028707127 | 1.54201028 | 2 | 71 | 2 | 17906 | ANLN,P2RX7 |
GO:BP | Galactosylceramide metabolic process | GO:0006681 | 0.029707822 | 1.52712919 | 9 | 105 | 3 | 17906 | UGT8,FA2H,GAL3ST1 |
GO:BP | Negative regulation of cell development | GO:0010721 | 0.029857665 | 1.52494416 | 350 | 160 | 13 | 17906 | SPP1,MAG,NKX6-2,CNTN2,TMEM98,SEMA4D,CERS2,ZNF536,SEMA6A,SEMA3B,DAAM2,SOX10,MAP4K4 |
GO:BP | Drug transmembrane transport | GO:0006855 | 0.032057254 | 1.49407368 | 75 | 2 | 2 | 17906 | LRP2,AQP1 |
GO:BP | Generation of neurons | GO:0048699 | 0.033131105 | 1.47976408 | 1574 | 166 | 32 | 17906 | LRP2,SLC45A3,PLP1,KLK6,UGT8,SPP1,GLDN,ASPA,C21ORF91,MAG,S1PR5,NKX6-2,CNTN2,DOCK10,TMEM98,USH1C,SEMA4D,TNC,NDE1,CERS2,ZNF536,SEMA6A,SEMA3B,MAN2A1,DAAM2,KIF13B,WHRN,FRYL,SFRP1,SOX10,MAP4K4,LTK |
GO:BP | Ceramide metabolic process | GO:0006672 | 0.034955601 | 1.45648322 | 94 | 105 | 6 | 17906 | UGT8,ELOVL1,FA2H,P2RX7,CERS2,GAL3ST1 |
GO:BP | Transmembrane transport | GO:0055085 | 0.038251324 | 1.41735353 | 1634 | 73 | 19 | 17906 | LRP2,AQP1,PIEZO2,KCNH8,SLC45A3,ABCA8,TMEM144,GJB1,TF,SGK2,TMEM63A,DYSF,SLC5A11,CLCA4,TTYH2,CAPN3,SLC44A1,P2RX7,SLC26A9 |
GO:BP | Cellular component assembly involved in morphogenesis | GO:0010927 | 0.039919771 | 1.39881196 | 114 | 132 | 7 | 17906 | UGT8,LDB3,CAPN3,CD9,ABCA2,PHLDB1,CFL2 |
GO:BP | Galactolipid metabolic process | GO:0019374 | 0.042258663 | 1.37408425 | 10 | 105 | 3 | 17906 | UGT8,FA2H,GAL3ST1 |
GO:BP | Regulation of plasma membrane bounded cell projection organization | GO:0120035 | 0.045082781 | 1.3459893 | 694 | 166 | 19 | 17906 | ANLN,KLK6,ENPP2,SPP1,C21ORF91,MAG,CNTN2,P2RX7,USH1C,SEMA4D,CERS2,PLD1,CDC42EP1,SEMA6A,SEMA3B,KIF13B,SFRP1,MAP4K4,LTK |
GO:BP | Regulation of cellular component size | GO:0032535 | 0.049709667 | 1.30355914 | 383 | 132 | 12 | 17906 | AQP1,SPP1,MAG,CNTN2,P2RX7,USH1C,SEMA4D,WIPF1,CDC42EP1,SEMA6A,SEMA3B,CFL2 |